Even when all the original tumor ECs are killed, AATs still can trigger a dramatic release of VEGF-enriched exosomes from these ECs to promote EC vasculogenesis and VM in other locations (Zeng et al., 2019; Figure 2). This evidence concerns the gene VEGFA and neoplasm.